Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
SpectraScience Raises $4.3M
|
Bruce V. Bigelow |
11/06/09 |
San Diego
|
|
Gloucester Pharma Wins FDA Approval of Drug for Rare Skin Cancer
|
Luke Timmerman |
11/05/09 |
Boston
|
|
Light Sciences Oncology Lines Up Extra $35M Financing For Targeted Cancer Treatment
|
Luke Timmerman |
11/05/09 |
Seattle
|
|
Dendreon Files FDA Application, DxBox Reaches Turning Point, ISB to Do 100 Genomes, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
11/05/09 |
Seattle
|
|
Calypso Teams Up with Siemens
|
Gregory T. Huang |
11/03/09 |
Seattle
|
|
On-Q-ity Raises $21M in A Round for Personalized Cancer Testing
|
Ryan McBride |
11/03/09 |
Boston
|
|
Dendreon Files Provenge Application to FDA Ahead of Schedule, Now It’s Time to Wait
|
Luke Timmerman |
11/02/09 |
Seattle
|
|
Virdante Pharma Lands $30M in A Round to Combat Inflammation
|
Ryan McBride |
10/29/09 |
Boston
|
|
TEDMED Sessions Seek the Patterns in Health Care and Life Sciences That Hold Ideas Together
|
Bruce V. Bigelow |
10/28/09 |
San Diego
|
|
Nuclea Nabs $3.4M Deal
|
Luke Timmerman |
10/22/09 |
Boston
|
|
Five Red Flags of a Biotech, Pathway Medical Learns Lessons, Amgen Faces FDA Delay, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/22/09 |
Seattle
|
|
Antigenics Shares Plummet as Cancer Vaccine Application Rejected in Europe
|
Luke Timmerman |
10/21/09 |
Boston
|
|
Augmenix Snags $6.1M
|
Luke Timmerman |
10/19/09 |
Boston
|
|
Calistoga Cancer Drug Shows “Encouraging” Preliminary Results in Small Study
|
Luke Timmerman |
10/19/09 |
Seattle
|
|
Top 10 Highlights from FiReGlobal: Michael Dell, Lee Hartwell, Irwin Jacobs, and More
|
Gregory T. Huang |
10/16/09 |
Seattle
|
|
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
Five Red Flags to Watch Out For in a Biotech, From Dendreon Co-Founder Chris Henney
|
Luke Timmerman |
10/15/09 |
Seattle
|
|
New Life Sciences Startup Shows UCSD Technology Can Boost Immune Response to Cancer in Mice
|
Bruce V. Bigelow |
10/14/09 |
San Diego
|
|
Amazon Invests in Engine Yard, PopCap Raises $22.5M, Omeros Goes Public, & More Seattle-Area Deals News
|
Gregory T. Huang |
10/14/09 |
Seattle
|
|
Lee Hood’s New Company Snags $30M to Spot Cancer and Alzheimer’s in Early Days
|
Luke Timmerman |
10/14/09 |
Seattle
|
|
Sirtris Advancing No. 1 Drug into Mid-Stage Clinical Trials for Type 2 Diabetes
|
Ryan McBride |
10/14/09 |
Boston
|
|
Seattle Genetics Adds Marketing Boss
|
Luke Timmerman |
10/13/09 |
Seattle
|
|
Dendreon Recruits Genentech CEO, Former Lilly Manufacturing Chief to Board
|
Luke Timmerman |
10/09/09 |
Seattle
|
|
Amgen’s Seattle and Boston Teams Seek to Boost Biotech Hit Rate 20 to 30 Percent
|
Luke Timmerman |
10/09/09 |
National
|
|
Polaris Picks Immuneering, Developer of Personalized Cancer Test, as First Life Sciences Startup in Dog Patch Incubator
|
Luke Timmerman |
10/08/09 |
Boston
|
|
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/08/09 |
Seattle
|
|
Epizyme Snags $32M Round to Make Drugs Against Cancer and More
|
Luke Timmerman |
10/07/09 |
Boston
|
|
Geospiza Wins NIH Cancer Grant
|
Luke Timmerman |
10/07/09 |
Seattle
|
|
Sage Bionetworks, Biology’s Open Source Spark, Snags “Major” Donation from Quintiles
|
Luke Timmerman |
10/06/09 |
Seattle
|
|
Genzyme Drug Fails to Win FDA Nod
|
Luke Timmerman |
10/06/09 |
Boston
|
|
Page 1 of
15 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
